|

 |
 |
An
interview with:
Prof. Manuel C. Peitsch |
 |

 |
cording
to Essential
Science Indicators ,
the paper "SWISS-MODEL and the Swiss-PdbViewer: an
environment for comparative protein modeling" (Guex N,
Peitsch MC, Electrophoresis 18[15]: 2714-23, December
1997) ranks at #2 among Chemistry papers published in the past
decade, with 2,684 citations to date. In the interview below,
in-cites talks with Professor Manuel Peitsch about this paper
and its impact on the field. Professor Peitsch is the Global
Head of Systems Biology, Genome and Protein Sciences at the
Novartis Institute of Biomedical Research in Basel,
Switzerland.
|
Would you give us some
background on your education and early research?
I am a biologist and physical chemist by training and obtained my
Ph.D. in Biochemistry from the University of Lausanne (Switzerland)
studying the antibody-independent activation of the classical
complement pathway. During that time I got increasingly interested
in protein structure as well as scientific computing. This led me to
spend my post-doctoral years in the Laboratory of Mathematical
Biology of the National Cancer Institute (Frederick, MD, USA) with
J.V. Maizel, where I started to write methods and software tools to
predict the 3D-structure of proteins using homology-based
approaches. After my return to Switzerland, I used these tools to
build an internet-based protein modeling server, which became
SWISS-MODEL in 1993, when I wrote its interface using Web-based
technology.
Would you please sum up your 1997 Electrophoresis paper on
SWISS-MODEL and Swiss-PdbViewer?
|

“One major driver behind our vision was to hide much of the complexity associated with protein modeling behind a simple and easy-to-use interface, thereby providing a very large community of scientists with the possibility to gain insights into the 3D structure of the proteins they are studying, without the need to learn and purchase complex and expensive software.”
|
|
When Nicolas Guex joined my group in 1995, we developed a vision
of a completely integrated environment for protein structures
prediction over the Web. Therefore we developed the Swiss-PdbViewer,
which not only operates as a stand-alone application for protein
structure analysis and modeling, but also acts as a client
application to the SWISS-MODEL and ExPASy web servers.
The paper describes the software components and provides an
example of their application. Furthermore, the paper describes the
notion of large-scale protein modeling and the associated protein
model repository, which later paved the way for the 3DCrunch
experiment run in collaboration with Silicon Graphics. At the end of
this experiment, the SWISS-MODEL Repository held over 64,000 model
structures (Peitsch MC, Schwede T, Guex N, "Automated protein
modeling—the proteome in 3D," Pharmacogenomics
1[3]:257-266, 2000).
What is it about this paper that caused it to become so highly cited?
One major driver behind our vision was to hide much of the
complexity associated with protein modeling behind a simple and
easy-to-use interface, thereby providing a very large community of
scientists with the possibility to gain insights into the 3D
structure of the proteins they are studying, without the need to
learn and purchase complex and expensive software.
There are probably four major factors contributing to the
citation record. First, the server is easy to use, as the
Web-interface takes away most of the complexity normally associated
with protein modeling. Second, the Swiss-PdbViewer, which is
available for most relevant computer platforms (MS, MAC, LINUX, and
SGI), has many powerful and easy-to-use features developed by
modelers for modelers. Third, the uninterrupted operations for 13
years allows over 50,000 users to build over 180,000 models and
access nearly 1 million models available in the SWISS-MODEL
Repository every year. And finally, Swiss-PdbViewer has an active
user community kindly and efficiently coordinated by Gale Rhodes of
the University of Southern Maine.
Where is this work today—have SWISS-MODEL and Swiss-PdbViewer been
upgraded in any significant way?
While the members of the original team moved on to new positions,
the collaboration is still ongoing, and all three components of the
environment are regularly upgraded and improved from an algorithmic,
technical, and user interface perspective. I would, however, like to
point out two significant developments by the group of Torsten
Schwede at the University of Basel: first, a Web-based personal
workspace which assists and guides the user in building protein
homology models at different levels of complexity; and second, a
completely reworked SWISS-MODEL Repository which now contains nearly
1 million model structures accompanied by detailed information about
the target protein, the model building process, and model quality
assessment.
Who, besides your scientific collaborators, was instrumental for the
success of SWISS-MODEL and Swiss-PdbViewer?
As a team we are particularly thankful to Timothy N.C. Wells (GlaxoWellcome,
now at Merck-Serono), Jonathan C.K. Knowles (GlaxoWellcome, now at
Roche), and Allan Baxter (GlaxoSmithKline) who have established the
necessary environment for this project. Furthermore we are deeply
indebted to Stanley K. Burt, Robert W. Lebherz, and Jack R. Collins
as well as the whole staff at the Advanced Biomedical Computing
Center at NCI-Frederick (Frederick, MD, USA) for their continuing
support and operating the US mirror of the SWISS-MODEL server.
If you are free to talk about it, what are your current projects?
In my current activities, I mainly focus on systems biology and
the integration of experimental and mathematical approaches to the
study of signaling networks. These include proteomics, computational
systems biology, and text mining. I do, however, still collaborate
with Torsten Schwede on SWISS-MODEL, Swiss-PdbViewer, and projects
to employ GRID-based computing to accelerate high-throughput docking
of small molecules into the binding pockets of protein structures.
Prof. Manuel C. Peitsch, Ph.D.
Global Head of Systems Biology
Genome and Proteome Sciences
Novartis Institute of BioMedical Research
Novartis Pharma AG
Basel, Switzerland
| Prof. Manuel C. Peitsch's
most-cited paper with 701 cites to date: |
|
Guex N, Peitsch MC, "SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling,"
Electrophoresis 18(15): 2714-23, December 1997. 2,684 cites.
|
|
Source:
Essential Science Indicators |
|
|
|